当前位置: 首页 > 详情页

Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, [2]Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, [3]Shanxi University of Traditional Chinese Medicine, Taiyuan, China, [4]Department of Neurology, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, United States
出处:
ISSN:

关键词: astrocytes complement-dependent cytotoxicity neuromyelitis optica-IgG IL-15 neuromyelitis optica

摘要:
Astrocyte loss induced by neuromyelitis optica (NMO)-IgG and complement-dependent cytotoxicity (CDC) is the hallmark of NMO pathology. The survival of astrocytes is thought to reflect astrocyte exposure to environmental factors in the CNS and the response of astrocytes to these factors. However, still unclear are how astrocytes respond to NMO-IgG and CDC, and what CNS environmental factors may impact the survival of astrocytes. In a murine model of NMO induced by intracerebral injection of NMO-IgG and human complement, we found dramatic upregulation of IL-15 in astrocytes. To study the role of astrocytic IL-15 in NMO, we generated a transgenic mouse line with targeted expression of IL-15 in astrocytes (IL-15(tg)), in which the expression of IL-15 is controlled by a glial fibrillary acidic protein promoter. We showed that astrocyte-targeted expression of IL-15 attenuates astrocyte injury and the loss of aquaporin-4 in the brain. Reduced blood-brain barrier leakage and immune cell infiltration are also found in the lesion of IL-15(tg) mice subjected to NMO induction. IL-15(tg) astrocytes are less susceptible to NMO-IgG-mediated CDC than their wild-type counterparts. The enhanced resistance of IL-15(tg) astrocytes to cytotoxicity and cell death involves NF-kappa B signaling pathway. Our findings suggest that IL-15 reduces astrocyte loss and NMO pathology.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区:
出版当年[2016]版:
Q1 IMMUNOLOGY
最新[2023]版:
Q1 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, [2]Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China,
通讯作者:
通讯机构: [1]Department of Neurology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China, [2]Center for Neuroinflammation, Beijing Tiantan Hospital, Capital Medical University, Beijing, China,
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院